KARMEN CLARK: Open Payments
NPI 1619035029 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,629 in 237 payments from 34 companies in 2025. Trend: 2023 $13,733 · 2024 $4,249 · 2025 $4,629
Food & beverage: $4,559Education: $70
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $755 |
| UCB, Inc. | 15 | $321 |
| Alexion Pharmaceuticals, Inc. | 14 | $303 |
| Neurocrine BioSciences, Inc. | 10 | $261 |
| PFIZER INC. | 19 | $245 |
| EMD Serono, Inc. | 8 | $243 |
| ACADIA Pharmaceuticals Inc | 16 | $228 |
| Biogen, Inc. | 11 | $221 |
| SK Life Science, Inc. | 8 | $206 |
| ARGENX US, INC. | 12 | $202 |
Products named: ULTOMIRIS, BOTOX, QULIPTA, INGREZZA, NUPLAZID, NURTEC ODT, VYVGART HYTRULO, ACTHAR.
Industry payments across MS — which companies pay providers there.
